Jan 1, 1997

HLA-DR typing by standard serology and PCR-amplification with sequence-specific primers: a comparative study

Zhonghua yi xue za zhi
J TanQ Xu

Abstract

DNA typing for HLA-DR by polymerase chain reaction with sequence-specific primers (PCR-SSP) compared with standard serology to evaluate the reliability and clinical practicability. Double-blind typing for HLA-DR alleles was carried out using DNA typing by PCR-SSP and standard serology by microlymphocytotoxicity technique in 61 donors and 101 recipients of cadaveric transplantation. Matching time, sensitivity, specificity and clinical practicability were compared according to typing results by both methods. All 162 samples were able to be typed by PCR-SSP. A total of 308 alleles were detected (16 DR "blank"). The results of matching were confirmed by analysis with restriction endonucleases and Southern hybridization. The specificity and reproducibility were 100%. HLA-DR typing was performed in 5 hours by PCR-SSP or 20 hours by serology. The discrepancy rate between PCR-SSP and serological HLA-DR typing was 30.2% (35.6% for kidney recipients, 21.3% for donors). The discrepancies consisted of 8 loci being doubtful, 29 antigens being incorrectly interpreted by serology and 20 of serological "blanks" turning out to be definable alleles by the DNA method. Genotyping for HLA-DR by PCR-SSP offers the advantages of better reagent and sa...Continue Reading

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Southern Hybridization
Graft-vs-Host Disease
Gene Amplification Technique
Study of Serum
Antigens
HLA-DR Antigens
HLA Typing
Sample Serology (Procedure)
DNA Restriction Enzymes
Gene Amplification Abnormality

About this Paper

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.